Influence of donor post-reperfusion changes on graft evolution after liver transplant

Revista Espanola de Enfermedades Digestivas

Volumn 93, Issue 1, 2001, Pages 44-47

  Busquets, J ^a   Serrano, T ^a   Figueras, Juan ^a   Ramos, E ^a   Torras, J ^a   Rafecas, A ^a   Fabregat, J ^a   Xiol, X ^a   Lama, C ^a   Ibanez L ^a   Jaurrieta, E ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Biliary complications; Graft dysfunction; Hepatic transplant; Steatosis

Indexed keywords

ARTICLE; BIOPSY; GRAFT SURVIVAL; HUMAN; LIVER; LIVER TRANSPLANTATION; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; REPERFUSION; RISK FACTOR; STATISTICAL ANALYSIS;

ACTUARIAL ANALYSIS; BIOPSY; GRAFT SURVIVAL; HUMANS; LIVER; LIVER TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; REPERFUSION; RISK FACTORS;

EID: 0035233320     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Organización Nacional de Trasplantes. Informe anual sobre trasplante hepático. Madr d, España 1999.
2. National Institutes of Health Consensus Development Conference Statement in Liver Transplantation. Hepatology 1984; 4: 107S-110S.
3. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation. A multivariable analysis. Transplantation 1993; 55: 807-13.
4. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 823-38.
5. Mor E, Klintmalm GB, Gonwa TA. Solomon H, Holman MJ, Gibbs JF, et al. The use of marginal donors for liver transplantation. Transplantation 1992; 53: 383-6.
6. Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, Martin P, et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995; 60: 790-4.
7. Emre S, Schwartz ME, Altaca G, Sezhi P, Fiel MI, Guy SR, et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996; 62 62-5.
8. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. Use of fatty donor liver is associated with diminished early patients and graft survival. Transplantation 1996; 62: 1246-51.
9. Yoong KF, Gunson BK, Neil DAH, Mirza DF, Mayer AD, Buckels JAC, et al. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc 1999; 31: 550-1.
10. Sheiner P, Emre S, Cubukcu O, Thung S, Guy S, Fisher A, et al. Use of donor livers with moderate-to-severe microvesicularfat. Hepatology 1995; 22: 205 A.
11. Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997; 64: 248-51.
12. Kakizoe S, Yaraga K, Starzl TE, Demetris AJ. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology 1990; 11: 932-41.
13. Gaffey MJ, Boyd JC, Traweek ST, Ali A, Rezeig M, Caldwell SH, et al. Predictive value of intraoperative biopsies and liver function test for preservation injury in orhotopic liver transplantation. Hepatology 1997; 25: 184-9.
14. Adam R, Bismuth H, Diamond T, Ducot B, Morino M, Astarcioglu I, et al. Effect of extended cold ischemia with UW solution on graft function after liver transplantation. Lancet 1992; 340: 1373-6.
15. González FX, Rimola A, Grande L, Antolín M, García-Valdecasas JC, Fuster J, et al. Predictive factors of early graft function in human liver transplantation. Hepatology 1994; 20: 565-73.
16. Avolio AW, Agnes S, Chirico ASA, Castagneto M. Primary dysfunction after liver transplantation: donor or recipient fault? Transplantation Proc 1999; 31: 434-6.